Leaf Pharma

Mounjaro 5mg KwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger.
Mounjaro 5mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.
Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 5mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.Common side effects of Mounjaro 5mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). 

Uses of Mounjaro KwikPen  • To improve glycemic control in adults with Type 2 diabetes mellitus  • Management of Obesity
Benefits of Mounjaro KwikPenIn To improve glycemic control in adults with Type 2 diabetes mellitusMounjaro 5mg KwikPen stimulates the body’s natural insulin response when blood sugar is high. It also reduces glucagon secretion, preventing excessive glucose production simultaneously. This dual action helps lower blood sugar levels and improve long-term glucose control.

Side Effects of Mounjaro KwikPenMost side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Mounjaro  • Nausea  • Vomiting  • Diarrhea  • Abdominal pain  • Indigestion  • Constipation
How To Use Mounjaro KwikPen  • Your doctor or nurse will guide you how to use this medicine.
How Mounjaro KwikPen worksMounjaro 5mg KwikPen helps control blood sugar and support weight loss by imitating the effects of two natural hormones—GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) in your body. It helps your body release insulin when blood sugar is high and lowers the hormone that raises blood sugar. It also slows down the rate at which food leaves your stomach, so you feel full for longer and eat less.

Safety adviceAlcoholIt is not known whether it is safe to consume alcohol with Mounjaro 2.5mg KwikPen. Please consult your doctor.
PregnancyThe safety of Mounjaro 5mg KwikPen during pregnancy has not been established. There are no adequate and well-controlled studies in pregnant women, and animal data on reproductive toxicity are insufficient. Your doctor will weigh the benefits and any potential risks before prescribing

Breast feedingInformation regarding the use of Mounjaro 5mg KwikPen during breastfeeding is not available. Please consult your doctor.
DrivingIt is not known whether Mounjaro 5mg KwikPen alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react. Please consult your doctor.
KidneyMounjaro 5mg KwikPen is safe to use in patients with kidney disease. No dose adjustment is recommended.
LiverMounjaro 5mg KwikPen is safe to use in patients with liver disease. No dose adjustment is recommended.

Mounjaro Tirzepatide 15mg KwikPen

Product IntroductionMounjaro 15mg KwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger.
Mounjaro 15mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.
Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 15mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.Common side effects of Mounjaro 15mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.

Uses of Mounjaro KwikPen• To improve glycemic control in adults with Type 2 diabetes mellitus• Management of Obesity
Benefits of Mounjaro KwikPenIn To improve glycemic control in adults with Type 2 diabetes mellitusMounjaro 15mg KwikPen stimulates the body’s natural insulin response when blood sugar is high. It also reduces glucagon secretion, preventing excessive glucose production simultaneously. This dual action helps lower blood sugar levels and improve long-term glucose control.
Side Effects of Mounjaro KwikPenMost side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Mounjaro• Nausea• Vomiting• Diarrhea• Abdominal pain• Indigestion• Constipation
How To Use Mounjaro KwikPen• Your doctor or nurse will guide you how to use this medicine.
How Mounjaro KwikPen worksMounjaro 15mg KwikPen helps control blood sugar and support weight loss by imitating the effects of two natural hormones—GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) in your body. It helps your body release insulin when blood sugar is high and lowers the hormone that raises blood sugar. 
Safety adviceAlcoholIt is not known whether it is safe to consume alcohol with Mounjaro 15mg KwikPen. Please consult your doctor.
PregnancyThe safety of Mounjaro 15mg KwikPen during pregnancy has not been established. There are no adequate and well-controlled studies in pregnant women, and animal data on reproductive toxicity are insufficient. Your doctor will weigh the benefits and any potential risks before prescribing.

Breast feedingInformation regarding the use of Mounjaro 15mg KwikPen during breastfeeding is not available. Please consult your doctor.They will weigh its benefits against potential risks to the infant and advise you accordingly.
DrivingIt is not known whether Mounjaro 15mg KwikPen alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react. Please consult your doctor.

Mounjaro Tirzepatide 12.5mg KwikPen

Product IntroductionMounjaro 12.5mg KwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger.
Mounjaro 12.5mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.
Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 12.5mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.Common side effects of Mounjaro 12.5mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.

Uses of Mounjaro KwikPen• To improve glycemic control in adults with Type 2 diabetes mellitus• Management of Obesity
Benefits of Mounjaro KwikPenIn To improve glycemic control in adults with Type 2 diabetes mellitusMounjaro 12.5mg KwikPen stimulates the body’s natural insulin response when blood sugar is high. It also reduces glucagon secretion, preventing excessive glucose production simultaneously. This dual action helps lower blood sugar levels and improve long-term glucose control.
Side Effects of Mounjaro KwikPenMost side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about themCommon side effects of Mounjaro• Nausea• Vomiting• Diarrhea• Abdominal pain• Indigestion• Constipation
How To Use Mounjaro KwikPen• Your doctor or nurse will guide you how to use this medicine.
How Mounjaro KwikPen  worksMounjaro 12.5mg KwikPen helps control blood sugar and support weight loss by imitating the effects of two natural hormones—GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) in your body. It helps your body release insulin when blood sugar is high and lowers the hormone that raises blood sugar. It also slows down the rate at which food leaves your stomach, so you feel full for longer and eat less.
Safety adviceAlcoholIt is not known whether it is safe to consume alcohol with Mounjaro 12.5mg KwikPen. Please consult your doctor.
PregnancyThe safety of Mounjaro 12.5mg KwikPen during pregnancy has not been established. There are no adequate and well-controlled studies in pregnant women, and animal data on reproductive toxicity are insufficient. Your doctor will weigh the benefits and any potential risks before prescribing.
Breast feedingInformation regarding the use of Mounjaro 12.5mg KwikPen during breastfeeding is not available. Please consult your doctor.They will weigh its benefits against potential risks to the infant and advise you accordingly.
DrivingIt is not known whether Mounjaro 12.5mg KwikPen alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react. Please consult your doctor.

Mounjaro Tirzepatide 10mg KwikPen

Product Introduction  
Mounjaro 10mg KwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger.
Mounjaro 10mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.
Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 10mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.Common side effects of Mounjaro 10mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.

Uses of Mounjaro KwikPen  • To improve glycemic control in adults with Type 2 diabetes mellitus  • Management of Obesity
Benefits of Mounjaro KwikPenIn To improve glycemic control in adults with Type 2 diabetes mellitusMounjaro 10mg KwikPen stimulates the body’s natural insulin response when blood sugar is high. It also reduces glucagon secretion, preventing excessive glucose production simultaneously. This dual action helps lower blood sugar levels and improve long-term glucose control.
Side Effects of Mounjaro KwikPenMost side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about themCommon side effects of Mounjaro  • Nausea  • Vomiting  • Diarrhea  • Abdominal pain  • Indigestion  • Constipation
How To Use Mounjaro KwikPen  • Your doctor or nurse will guide you how to use this medicine.
How Mounjaro KwikPen worksMounjaro 10mg KwikPen helps control blood sugar and support weight loss by imitating the effects of two natural hormones—GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) in your body. It helps your body release insulin when blood sugar is high and lowers the hormone that raises blood sugar. It also slows down the rate at which food leaves your stomach, so you feel full for longer and eat less. 
Safety adviceAlcoholIt is not known whether it is safe to consume alcohol with Mounjaro 10mg KwikPen. Please consult your doctor.
PregnancyThe safety of Mounjaro 10mg KwikPen during pregnancy has not been established. There are no adequate and well-controlled studies in pregnant women, and animal data on reproductive toxicity are insufficient.
Breast feedingInformation regarding the use of Mounjaro 10mg KwikPen during breastfeeding is not available. Please consult your doctor.They will weigh its benefits against potential risks to the infant and advise you accordingly.
DrivingIt is not known whether Mounjaro 10mg KwikPen alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react. Please consult your doctor.

Mounjaro Tirzepatide 2.5mg KwikPen

Product Introduction  
Mounjaro 2.5mg KwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger.
Mounjaro 2.5mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.
Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 2.5mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.Common side effects of Mounjaro 2.5mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.

Uses of Mounjaro KwikPen• To improve glycemic control in adults with Type 2 diabetes mellitus• Management of Obesity


Benefits of Mounjaro KwikPenIn To improve glycemic control in adults with Type 2 diabetes mellitusMounjaro 2.5mg KwikPen stimulates the body’s natural insulin response when blood sugar is high. It also reduces glucagon secretion, preventing excessive glucose production simultaneously. This dual action helps lower blood sugar levels and improve long-term glucose control.


Side effects of Mounjaro KwikPenMost side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Mounjaro• Nausea• Vomiting• Diarrhea• Abdominal pain• Indigestion• Constipation

How to use Mounjaro KwikPen• Your doctor or nurse will guide you how to use this medicine.


How Mounjaro KwikPen  worksMounjaro 2.5mg KwikPen helps control blood sugar and support weight loss by imitating the effects of two natural hormones—GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) in your body. It helps your body release insulin when blood sugar is high and lowers the hormone that raises blood sugar. It also slows down the rate at which food leaves your stomach, so you feel full for longer and eat less. 


Safety advice
AlcoholIt is not known whether it is safe to consume alcohol with Mounjaro 2.5mg KwikPen. Please consult your doctor.
PregnancyThe safety of Mounjaro 2.5mg KwikPen during pregnancy has not been established. There are no adequate and well-controlled studies in pregnant women, and animal data on reproductive toxicity are insufficient.
Breast feedingInformation regarding the use of Mounjaro 2.5mg KwikPen during breastfeeding is not available. Please consult your doctor.They will weigh its benefits against potential risks to the infant and advise you accordingly.
DrivingIt is not known whether Mounjaro 2.5mg KwikPen alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react. Please consult your doctor.
KidneyMounjaro 2.5mg KwikPen is safe to use in patients with kidney disease. No dose adjustment is recommended.

Mounjaro Tirzepatide 7.5mg KwikPen

Product Introduction  
Mounjaro 7.5mg KwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger.
Mounjaro 7.5mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.

Uses of Mounjaro KwikPen  • To improve glycemic control in adults with Type 2 diabetes mellitus  • Management of Obesity

Benefits of Mounjaro KwikPenIn To improve glycemic control in adults with Type 2 diabetes mellitusMounjaro 7.5mg KwikPen stimulates the body’s natural insulin response when blood sugar is high. It also reduces glucagon secretion, preventing excessive glucose production simultaneously. This dual action helps lower blood sugar levels and improve long-term glucose control.

Side Effects of Mounjaro KwikPenMost side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about themCommon side effects of Mounjaro  • Nausea  • Vomiting  • Diarrhea  • Abdominal pain  • Indigestion  • Constipation

How To Use Mounjaro KwikPen  • Your doctor or nurse will guide you how to use this medicine.

How Mounjaro KwikPen worksMounjaro 7.5mg KwikPen helps control blood sugar and support weight loss by imitating the effects of two natural hormones—GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) in your body. It helps your body release insulin when blood sugar is high and lowers the hormone that raises blood sugar. It also slows down the rate at which food leaves your stomach, so you feel full for longer and eat less. By acting on your brain to reduce hunger, this medicine helps you manage blood sugar better and lose weight more effectively than other medicines that target only one hormone.

Safety adviceAlcoholIt is not known whether it is safe to consume alcohol with Mounjaro 7.5mg KwikPen. Please consult your doctor.
PregnancyThe safety of Mounjaro 7.5mg KwikPen during pregnancy has not been established. There are no adequate and well-controlled studies in pregnant women, and animal data on reproductive toxicity are insufficient. Your doctor will weigh the benefits and any potential risks before prescribing.
Breast feedingInformation regarding the use of Mounjaro 7.5mg KwikPen during breastfeeding is not available. Please consult your doctor.They will weigh its benefits against potential risks to the infant and advise you accordingly.
DrivingIt is not known whether Mounjaro 7.5mg KwikPen alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react. Please consult your doctor.
KidneyMounjaro 7.5mg KwikPen is safe to use in patients with kidney disease. No dose adjustment is recommended.
LiverMounjaro 7.5mg KwikPen is safe to use in patients with liver disease. No dose adjustment is recommended.